CD274 and metastatic melanoma: The mean expression of COX-2 was 30.9 ± 23.0%, 35.7 ± 21.4% and 48.7 ± 21.2% in metastatic melanoma lesions which were scored for PD-L1 as negative, light positive and positive, respectively (Fig. 3b).